Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)

Clinical trial NCT05924074 · RECRUITING

Trial details

NCT number: NCT05924074
Sponsor: University Hospital, Bordeaux
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Ferroptosis

Start date: 2025-02-21
Primary completion: 2027-02-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.